ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Preserving the sanctity of overall survival for drugs approved on the basis of progression-free survival: tivozanib as a case study.

Marc B GarnickPubMed ↗Publisher ↗

No numbers read from the abstract.